D. Thommen
Immunology · 2018–2022
A researcher in the Science corpus: 4 papers; trusts 11 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 179 citations into it
- Oncology — 152 citations into it
Whom D. Thommen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- E. Wherry
- Shane Crotty
- I. Mellman
- P. Robbins
- A. Schietinger
- C. Sautès-Fridman
- C. Robert
- Nicholas McGranahan
- Robert Schreiber
- T. Gajewski
Who trusts D. Thommen overall
Papers from D. Thommen's perspective
Ordered by how strongly the researchers D. Thommen trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular signature of CD8+ T cell exhaustion during chronic viral infection. (Immunity)
- T cell exhaustion (Nature Immunology)
- CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms (Molecular and Cellular Biology)
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity (Journal of Experimental Medicine)
- Safety and clinical activity of combined PD-1 (nivolumab) and CTLA-4 (ipilimumab) blockade in advanced melanoma patients (New England Journal of Medicine)
- Coregulation of CD8+ T cell exhaustion during chronic viral infection by multiple inhibitory receptors (Nature Immunology)
- The CD28 signaling pathway regulates glucose metabolism. (Immunity)
- PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression (Nature)
- Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells (Nature Medicine)
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
Their papers
- Tertiary lymphoid structures in cancer (2022) — 937 citations
- CD8+ T cell states in human cancer: insights from single-cell analysis (2020) — 1,185 citations
- T Cell Dysfunction in Cancer (2018) — 1,105 citations
- A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small cell lung cancer treated with PD-1 blockade (2018) — 1,018 citations